Relationships between vascular oxygen sensing mechanisms and hypertensive disease processes

Hypertension

Volumn 60, Issue 2, 2012, Pages 269-275

  Gupte, Sachin A ^a   Wolin, Michael S ^b  

^a UNIVERSITY OF SOUTH ALABAMA   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; OXYGEN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2;

ARTICLE; BLOOD FLOW; DIMERIZATION; ENZYME ACTIVITY; HUMAN; HYPERTENSION; HYPOXIA; HYPOXIC LUNG VASOCONSTRICTION; METABOLIC REGULATION; NONHUMAN; OXIDATION REDUCTION POTENTIAL; OXYGEN SENSING; PRIORITY JOURNAL; SENSOR;

ANOXIA; HUMANS; HYPERTENSION, PULMONARY; OXYGEN; PULMONARY ARTERY; REGIONAL BLOOD FLOW; VASOCONSTRICTION;

EID: 84864280597     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.112.190702     Document Type: Article

References (66)

1. Gupte SA, Wolin MS. Oxidant and redox signaling in vascular oxygen sensing: implications for systemic and pulmonary hypertension. Antioxid Redox Signal. 2008;10:1137-1152. (Pubitemid 351451711)
2. Bärtsch P, Gibbs JSR. Effect of altitude on the heart and the lungs. Circulation. 2007;116:2191-2202. (Pubitemid 350060357)
3. Chaouat A, Naeije R, Weitzenblum E. Pulmonary hypertension in COPD. Eur Respir J. 2008;32:1371-1385.
4. Hanna JM. Climate, altitude and blood pressure. Hum Biol. 1999;71: 553-582.
5. Prewitt RL, Cardoso SS, Wood WB. Prevention of arteriolar rarefaction in the spontaneously hypertensive rat by exposure to simulated high altitude. J Hypertens. 1986;4:735-740. (Pubitemid 17217655)
6. Tripathy V, Gupta R. Blood pressure variation among Tibetans at different altitudes. Ann Human Biol. 2007;34:470-483. (Pubitemid 47057151)
7. Fiori G, Facchini F, Pettener D, Rimondi A, Battistini N, Bedogni G. Relationships between blood pressure, anthropometric characteristics and blood lipids in high-And low-Altitude populations from Central Asia. Ann Hum Biol. 2000;27:19-28. (Pubitemid 30049453)
8. Morrell NW, Adnot S, Archer SL, Dupuis J, Jones PL, MacLean MR, McMurtry IF, Stenmark KR, Thistlethwaite PA, Weissmann N, Yuan JX, Weir EK. Cellular and molecular basis of pulmonary arterial hypertension. J Am Coll Cardiol. 2009;4:S20-S31.
9. Sylvester JT, Shimoda LA, Aaronson PI, Ward JPT. Hypoxic pulmonary vasoconstriction. Physiol Rev. 2012;92:367-520.
10. Stasch J-P, Pacher P, Evgenov OV. Soluble guanylate cyclase as an emerging therapeutic target in cardiopulmonary disease. Circulation. 2011;123:2263-2273.
11. Neo BH, Kandhi S, Ahmad M, Wolin MS. Redox regulation of guanylate cyclase and protein kinase G in vascular responses to hypoxia. Respir Physiol Neurobiol. 2010;174:259-264.
12. Waypa GB, Schumacker PT. Hypoxia-induced changes in pulmonary and systemic vascular resistance: where is the O2 sensor?Respir Physiol Neurobiol. 2010;174:201-211.
13. Weir EK, Archer SL. The role of redox changes in oxygen sensing. Respir Physiol Neurobiol. 2010;174:182-191.
14. Gupte RS, Rawat DK, Chettimada S, Cioffi DL, Wolin MS, Gerthoffer WT, McMurtry IF, Gupte SA. Activation of glucose-6-phosphate dehydrogenase promotes acute hypoxic pulmonary artery contraction. J Biol Chem. 2010;285:19561-19571.
15. Gao Q, Wolin MS. Effects of hypoxia on relationships between cytosolic and mitochondrial NAD(P)H redox and superoxide generation in coronary arterial smooth muscle. Am J Physiol Heart Circ Physiol. 2008;295:H978-H989.
16. Gupte SA, Kaminski PM, Floyd B, Agarwal R, Ali N, Ahmad M, Edwards J, Wolin MS. Cytosolic NADPH may regulate differences in basal Nox oxidase-derived superoxide generation in bovine coronary and pulmonary arteries. Am J Physiol Heart Circ Physiol. 2005;288: H13-H21. (Pubitemid 40023822)
17. Gupte SA, Wolin MS. Hypoxia promotes relaxation of bovine coronary arteries through lowering cytosolic NADPH. Am J Physiol Heart Circ Physiol. 2006;290:H2228-H2238. (Pubitemid 43846049)
18. Deussen A, Brand M, Pexa A, Weichsel J. Metabolic coronary flow regulation-current concepts. Basic Res Cardiol. 2006;101:453-464. (Pubitemid 44637861)
19. Duncker DJ, Bache RJ. Regulation of coronary blood flow during exercise. Physiol Rev. 2008;88:1009-1086.
20. Weissmann N, Nollen M, Gerigk B, Ghofrani HA, Schermuly RT, Gunther A, Quanz K, Fink L, Hanze J, Rose F, Seeger W, Grimminger F. Downregulation of hypoxic vasoconstriction by chronic hypoxia in rabbits: effects of nitric oxide. Am J Physiol Heart Circ Physiol. 2003;284: H931-H938. (Pubitemid 36228242)
21. Gupte SA, Zias EA, Sarabu MR, Wolin MS. Role of prostaglandins in mediating differences in human internal mammary and radial artery relaxation elicited by hypoxia. J Pharmacol Exp Ther. 2004;311: 510-518. (Pubitemid 39391535)
22. Coburn RF, Moreland S, Moreland RS, Baron CB. Rate-limiting energydependent steps controlling oxidative metabolism-contraction coupling in rabbit aorta. J Physiol. 1992;448:473-492.
23. Gao Q, Zhao X, Ahmad M, Wolin MS. Mitochondrial-derived hydrogen peroxide inhibits relaxation of bovine coronary arterial smooth muscle to hypoxia through stimulation of ERK MAP kinase. Am J Physiol Heart Circ Physiol. 2009;297:H2262-H2269.
24. Thorne GD, Ishida Y, Paul RJ. Hypoxic vasorelaxation: Ca2-dependent and Ca2-independent mechanisms. Cell Calcium. 2004;36:201-208. (Pubitemid 38996756)
25. Yasuo I, Katherine C, Williamson JR. NADH augments blood flow in physiologically activated retina and visual cortex. Proc Natl Acad Sci USA. 2004;101:653-658. (Pubitemid 38084692)
26. Ely SW, Sun CW, Knabb RM, Gidday JM, Rubio R, Berne RM. Adenosine and metabolic regulation of coronary blood flow in dogs with renal hypertension. Hypertension. 1983;5:943-950. (Pubitemid 14214830)
27. Nyberg M, Jensen LG, Thaning P, Hellsten Y, Mortensen SP. Role of nitric oxide and prostanoids in the regulation of leg blood flow and blood pressure in humans with essential hypertension: effect of high-intensity aerobic training. J Physiol. 2012;590:1481-1494.
28. Weber DS, Lombard JH. Elevated salt intake impairs dilation of rat skeletal muscle resistance arteries via ANG II suppression. Am J Physiol Heart Circ Physiol. 2000;278:H500-H506. (Pubitemid 30131250)
29. Humbert M, Morrell NW, Archer SL, Stenmark KR, MacLean MR, Lang IM, Christman BW, Weir EK, Eickelberg O, Voelkel NF Rabinovitch M. Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol. 2004;43:13S-24S. (Pubitemid 38759713)
30. Feletou M, Vanhoutte PM. Endothelial dysfunction: A multifaceted disorder (The Wiggers Award Lecture). Am J Physiol Heart Circ Physiol. 2006;91:H985-H1002. (Pubitemid 44343640)
31. Paravicini TM, Touyz RM. Redox signaling in hypertension. Cardiovasc Res. 2006;71:247-258.
32. Guazzi MD, Alimento M, Berti M, Fiorentini C, Galli C, Tamborini G. Enhanced hypoxic pulmonary vasoconstriction in hypertension. Circulation. 1989;79:337-343. (Pubitemid 19055504)
33. Harrison DG, Guzik TJ, Lob HE, Madhur MS, Marvar PJ, Thabet SR, Vinh A, Weyand CM. Inflammation, immunity, and hypertension. Hypertension. 2011;57:132-140.
34. Hassoun PM, Mouthon L, Barbera JA, Eddahibi S, Flores SC, Grimminger F, Jones PL, Maitland ML, Michelakis ED, Morrell NW, Newman JH, Rabinovitch M, Schermuly R, Stenmark KR, Voelkel NF, Yuan JX, Humbert M. Inflammation, growth factors, and pulmonary vascular remodeling. J Am Coll Cardiol. 2009;54:S10-S19.
35. Liu J, Zelko I, Erbynn E, Sham J, Folz R. Hypoxic pulmonary hypertension: Role of superoxide and nadph oxidase (gp91phox). Am J Physiol Lung Cell Mol Physiol. 2006;290:L2-L10.
36. Semenza GL. Hypoxia-inducible factors in physiology and medicine. Cell. 2012;148:399-408.
37. Archer SL, Gomberg-Maitland M, Maitland ML, Rich S, Garcia JGN, Weir EK. Mitochondrial metabolism, redox signaling, and fusion: A mitochondria-ROS-HIF-1- Kv1.5 O2-sensing pathway at the intersection of pulmonary hypertension and cancer. Am J Physiol Heart Circ Physiol. 2008;294:H570-H578. (Pubitemid 351253263)
38. Alexanderm MR, Owens GK. Epigenetic control of smooth muscle cell differentiation and phenotypic switching in vascular development and disease. Annu Rev Physiol. 2012;74:13-40.
39. Liu Y, Sinha S, McDonald OG, Shang Y, Hoofnagle MH, Owens GK. Kruppel-like factor 4 abrogates myocardin-induced activation of smooth muscle gene expression. J Biol Chem. 2005;280:9719-9727. (Pubitemid 40409670)
40. Zhou W, Negash S, Liu J, Raj JU. Modulation of pulmonary vascular smooth muscle cell phenotype in hypoxia: role of cGMP-dependent protein kinase and myocardin. Am J Physiol Lung Cell Mol Physiol. 2009;296:L780-L789.
41. Choi C, Sellak H, Brown FM, Lincoln TM. cGMP-dependent protein kinase and the regulation of vascular smooth muscle cell gene expression: possible involvement of Elk-1 sumoylation. Am J Physiol Heart Circ Physiol. 2010;299:H1660-H1670.
42. Chettimada S, Rawat DK, Dey N, Kobelja R, Simms Z, Wolin MS, Lincoln TM, Gupte SA. Glc-6-PDH and PKG contribute to hypoxiainduced decrease in contractile phenotype proteins and pulmonary artery contraction. Am J Physiol Lung Cell Mol Physiol. May 11, 2012. DOI: 10.1152/ajplung.00002.2012. http://ajplung. physiology.org/content/early/2012/05/07/ajplung.00002.2012.full.pdf-html. Accessed June 5, 2012.
43. Wamhoff BR, Bowles DK, Owens GK. Excitation-transcription coupling in arterial smooth muscle. Circ Res. 2006;98:868-878.
44. Xiao Q, Luo Z, Pepe AE, Margaritti A, Zeng L, Xu Q. Embryonic stem cell differentiation into smooth muscle cells is mediated by Nox4-produced H2O2. Am J Physiol Cell Physiol. 2009;296:C711-C723.
45. Cordes KR, Sheehy NT, White MP, Berry EC, Morton SU, Muth AN, Lee TH, Miano JM, Ivey KN, Srivastava D. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature. 2009;460: 705-710.
46. Davis BN, Hilyard AC, Nguyen PH, Lagna G, Hata A. Induction of microRNA-221 by platelet-derived growth factor signaling is critical for modulation of vascular smooth muscle phenotype. J Biol Chem. 2009; 284:3728-3738.
47. Long X, Miano JM. Transforming growth factor-1 (TGF-1) utilizes distinct pathways for the transcriptional activation of microRNA 143/145 in human coronary artery smooth muscle cells. J Biol Chem. 2011;286: 30119-30129.
48. Cucoranu I, Clempus R, Dikalova A, Phelan PJ, Ariyan S, Dikalov S, Sorescu D. NAD(P)H oxidase 4 mediates transforming growth factor-1-induced differentiation of cardiac fibroblasts into myofibroblasts. Circ Res. 2005;97:900-907. (Pubitemid 41552675)
49. Courboulin A, Paulin R, Giguère NJ, Saksouk N, Perreault T, Meloche J, Paquet ER, Biardel S, Provencher S, Côté J, Simard MJ, Bonnet S. Role for miR-204 in human pulmonary arterial hypertension. J Exp Med. 2011;208:535-548.
50. Paulin R, Meloche J, Jacob MH, Bisserier M, Courboulin A, Bonnet S. Dehydroepiandrosterone inhibits the Src/STAT3 constitutive activation in pulmonary arterial hypertension. Am J Physiol Heart Circ Physiol. 2011; 301:H1798-H1809.
51. Oka M, Karoor V, Homma N, Nagaoka T, Sakao E, Golembeski SM, Limbird J, Imamura M, Gebb SA, Fagan KA, McMurtry IF. Dehydroepiandrosterone upregulates soluble guanylate cyclase and inhibits hypoxic pulmonary hypertension. Cardiovasc Res. 2007;74:377-387. (Pubitemid 46693699)
52. Ghosh G, Subramanian IV, Adhikari N, Zhang X, Joshi HP, Basi D, Chandrashekhar YS, Hall JL, Roy S, Zeng Y, Ramakrishnan S. Hypoxiainduced microRNA-424 expression in human endothelial cells regulates HIF- isoforms and promotes angiogenesis. J Clin Invest. 2010;120: 4141-4154.
53. Sen CK, Gordillo GM, Khanna S, Roy S. Micromanaging vascular biology: tiny microRNAs play big band. J Vasc Res. 2009;46:527-540.
54. Shilo S, Roy S, Khanna S, Sen CK. Evidence for the involvement of miRNA in redox regulated angiogenic response of human microvascular endothelial cells. Arterioscler Thromb Vasc Biol. 2008;28:471-477.
55. Ufer C, Wang CC, Borchert A, Heydeck D, Kuhn H. Redox control in mammalian embryo development. Antioxid Redox Signal. 2010;13: 833-875.
56. Palm F, Nordquist L. Renal oxidative stress, oxygenation and hypertension. Am J Physiol Regul Integr Comp Physiol. 2011:301: R229-R241.
57. Rolfo A, Many A, Racano A, Tal R, Tagliaferro A, Ietta F, Wang J, Post M, Caniggia I. Abnormalities in oxygen sensing define early and late onset preeclampsia as distinct pathologies. PLoS One. 2011;5: e13288.
58. Tal R, Shaish A, Barshack I, Polak-Charcon S, Afek A, Volkov A, Feldman B, Avivi C, Harats D. Effects of hypoxia-inducible factor-1- overexpression in pregnant mice: possible implications for preeclampsia and intrauterine growth restriction. Am J Pathol. 2011;177:2950-2962.
59. Sharma S, Norris WE, Kalkunte S. Beyond the threshold: an etiological bridge between hypoxia and immunity in preeclampsia. J Reprod Immunol. 2010;85:112-116.
60. Lorquet S, Pequeux C, Munaut C, Foidart JM. Aetiology and physiopathology of preeclampsia and related forms. Acta Clin Belg. 2011;65: 237-241.
61. Dempsey JA, Veasley SC, Morgan BJ, O'Donnell CP. Pathophysiology of sleep apnea. Physiol Rev. 2010;90:47-112.
62. Zoccal DB, Machado BH. Coupling between respiratory and sympathetic activities as a novel mechanism underpinning neurogenic hypertension. Curr Hypertens Rep. 2011;13:229-236.
63. Ramar K, Caples SM. Vascular changes, cardiovascular disease and obstructive sleep apnea. Future Cardiol. 2011;7:241-249.
64. Monahan K, Redline S. Role of obstructive sleep apnea in cardiovascular disease. Curr Opin Cardiol. 2011;26:541-547.
65. Zhan G, Serrano F, Fenik P, Hsu R, Kong L, Pratico D, Klann E, Veasey SC. NADPH oxidase mediates hypersomnolence and brain oxidative injury in a murine model of sleep apnea. Am J Respir Crit Care Med. 2005;172:921-929. (Pubitemid 41369078)
66. Tahawi Z, Orolinova N, Joshua IG, Bader M, Fletcher EC. Altered vascular reactivity in arterioles of chronic intermittent hypoxic rats. J Appl Physiol. 2001;90:2007-2013.